Literature DB >> 6230061

Management of angioplasty complications, unsuccessful procedures and early and late failures.

R H Samson, S Sprayregen, F J Veith, L A Scher, S K Gupta, E Ascer.   

Abstract

Limb-salvage was the indication for 90% of 206 attempted PTAs in 175 patients between 1976 and 1982. Life-table patency rates at 4 years for the angiographically successful iliac PTA and femoropopliteal PTA were 78% and 50%, respectively. PTA of eight iliac, seven femoropopliteal, nine tibial, and two subclavian arteries and one autogenous saphenous vein graft (ASV) were unsuccessful. Of these, 17 subsequently underwent successful bypass grafts and five required below-knee amputations. Ten iliac, 37 femoropopliteal, four tibial, and two ASV graft PTAs failed. Of 20 repeat attempts at PTA, only two have achieved long-term patency. Appropriate surgery allowed limb salvage in 23 of 36 early failures (less than 3 months) and 12 of 14 late failures (greater than 3 months), and usually consisted of the same operation that would have been performed had PTA not been attempted. Fifty-two complications were classified according to the method of treatment. Fourteen warranted surgery, but in 10 this was successfully achieved by the same operation that would have been required had PTA not been performed.

Entities:  

Mesh:

Year:  1984        PMID: 6230061      PMCID: PMC1353338          DOI: 10.1097/00000658-198402000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  19 in total

1.  Selective clot lysis with low-dose streptokinase.

Authors:  C T Dotter; J Rösch; A J Seaman
Journal:  Radiology       Date:  1974-04       Impact factor: 11.105

2.  Long-term results in 100 consecutive patients treated by transluminal angioplasty.

Authors:  L Wierny; R Plass; W Porstmann
Journal:  Radiology       Date:  1974-09       Impact factor: 11.105

3.  The treatment of occlusive arterial disease by transluminal catheter angioplasty.

Authors:  E Zeitler; W Schoop; W Zahnow
Journal:  Radiology       Date:  1971-04       Impact factor: 11.105

4.  Percutaneous transluminal angioplasty: importance of anticoagulant and fibrinolytic drugs.

Authors:  L Horváth
Journal:  AJR Am J Roentgenol       Date:  1980-11       Impact factor: 3.959

5.  Percutaneous transluminal angioplasty: iliac and deep femoral arteries.

Authors:  A C Waltman
Journal:  AJR Am J Roentgenol       Date:  1980-11       Impact factor: 3.959

6.  Anatomic and hemodynamic evaluation of percutaneous transluminal angioplasty.

Authors:  P D Flanigan; J J Schuler; D G Spigos; L T Lim
Journal:  Surg Gynecol Obstet       Date:  1982-02

7.  Hemodynamic assessment of transluminal angioplasty for lower extremity ischemia.

Authors:  C S O'Mara; H L Neiman; W R Flinn; R J Herman; J S Yao; J J Bergan
Journal:  Surgery       Date:  1981-01       Impact factor: 3.982

8.  Percutaneous transluminal angioplasty: an angiographer's viewpoint.

Authors:  H L Neiman; T D Brandt; M Greenberg
Journal:  Arch Surg       Date:  1981-06

9.  Femoral, popliteal, and tibial arteries: percutaneous transluminal angioplasty.

Authors:  A J Greenfield
Journal:  AJR Am J Roentgenol       Date:  1980-11       Impact factor: 3.959

10.  Popliteal artery branches: percutaneous transluminal angioplasty.

Authors:  S Sprayregen; K W Sniderman; T A Sos; U Vieux; A Singer; F J Veith
Journal:  AJR Am J Roentgenol       Date:  1980-11       Impact factor: 3.959

View more
  3 in total

Review 1.  Endovascular surgery for peripheral arterial occlusive disease. A critical review.

Authors:  S S Ahn; D Eton; W S Moore
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

2.  Microvascular free myocutaneous flap for treatment of nonhealing ischemic ulcers of the lower extremity. A case report.

Authors:  C Del Campo; E A Tovar
Journal:  Tex Heart Inst J       Date:  1996

3.  Changing arteriosclerotic disease patterns and management strategies in lower-limb-threatening ischemia.

Authors:  F J Veith; S K Gupta; K R Wengerter; J Goldsmith; S P Rivers; C W Bakal; A M Dietzek; J Cynamon; S Sprayregen; M L Gliedman
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.